← Return to Promising news on targeting KRAS G12D mutations
DiscussionPromising news on targeting KRAS G12D mutations
Pancreatic Cancer | Last Active: Jan 8 8:51am | Replies (5)Comment receiving replies
Replies to "KRAS G12D TRIAL RECRUITING in 6 locations. This is not immunotherapy trial at John’s Hopkins and..."
Thank you, that is encouraging!